XML 16 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 17,164,177 $ 6,875,273
Investment in debt securities - available for sale, at fair value 7,985,886
Accrued interest receivable on investment securities 21,369
Advances and deposits on clinical programs and other current assets 1,660,695 1,352,670
Total current assets 18,824,872 16,235,198
Property and equipment (at cost, less accumulated depreciation and amortization) 294,551 405,363
Other assets:    
Deferred income tax asset 1,845,823 1,819,324
In-process research and development, net 13,366,234 15,736,491
Goodwill 1,976,101 1,976,101
Operating lease right-of-use assets, net 1,047,336 1,431,640
Other intangible assets, net 113,660 340,976
Deposits and other assets 58,761 333,274
Total other assets 18,407,915 21,637,806
Total assets 37,527,338 38,278,367
Current liabilities:    
Accounts payable - trade 2,244,847 2,862,949
Other accrued liabilities 2,458,532 2,303,547
Notes payable - current portion, net of deferred financing costs 1,116,663 1,840,228
Operating lease liability - current portion 433,413 387,733
Deferred revenue - current portion 500,000 500,000
Total current liabilities 6,753,455 7,894,457
Earn-out milestone liability 7,018,000 5,717,709
Notes payable - non-current portion, net of deferred financing costs 3,934,497 7,963,449
Operating lease liability - non-current portion 710,305 1,143,717
Deferred revenue - non-current portion 500,000 1,000,000
Total liabilities 18,916,257 23,719,332
Commitments and contingencies
Stockholders' equity:    
Preferred Stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at December 31, 2020 and 2019)
Common stock - $0.01 par value (112,500,000 shares authorized; 40,701,356 and 23,256,152 shares issued at December 31, 2020 and 2019, respectively, and 40,701,022 and 23,255,818 shares outstanding at December 31, 2020 and 2019, respectively) 407,014 232,562
Additional paid-in capital 330,289,596 304,885,663
Accumulated other comprehensive gain 42,778
Accumulated deficit (312,000,341) (290,516,780)
Total stockholders' equity before treasury stock 18,696,269 14,644,223
Treasury stock, at cost (334 shares at December 31, 2020 and 2019) (85,188) (85,188)
Total stockholders' equity 18,611,081 14,559,035
Total liabilities and stockholders' equity $ 37,527,338 $ 38,278,367